Which circulating level of 25-hydroxyvitamin D is appropriate?
Moderate Vitamin D deficiency causes secondary hyperparathyroidism and bone loss, leading to osteoporosis and fractures. Controversy exists which circulating level of 25-hydroxyvitamin D (25OH)D is appropriate. The high incidence of hip fractures at northern latitudes suggest a relationship with Vit...
Gespeichert in:
Veröffentlicht in: | Journal of steroid biochemistry and molecular biology 2004-05, Vol.89 (1-5), p.611-614 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 614 |
---|---|
container_issue | 1-5 |
container_start_page | 611 |
container_title | Journal of steroid biochemistry and molecular biology |
container_volume | 89 |
creator | Lips, Paul |
description | Moderate Vitamin D deficiency causes secondary hyperparathyroidism and bone loss, leading to osteoporosis and fractures. Controversy exists which circulating level of 25-hydroxyvitamin D (25OH)D is appropriate. The high incidence of hip fractures at northern latitudes suggest a relationship with Vitamin D deficiency. However, international studies show lower serum 25(OH)D levels in southern than in northern Europe. Serum 25(OH)D was not a risk factor for hip fractures in several epidemiological studies. The required serum 25(OH)D is usually established by assessing the point where serum parathyroid hormone (PTH) starts to rise. This point varied in several studies between 30 and 78
nmol/l. However, interlaboratory variation may also influence the apparent required serum 25(OH)D level. Dietary calcium intake influences serum PTH and serum PTH may influence the turnover of Vitamin D metabolites. A low calcium intake causes an increase of serum PTH and serum 1,25(OH)2D thereby decreasing the half life of serum 25(OH)D. While a low calcium intake may aggravate Vitamin D deficiency, a high calcium intake may have a Vitamin D sparing effect. With current knowledge, a global estimate for the appropriate serum 25(OH)D is 50
nmol/l. |
doi_str_mv | 10.1016/j.jsbmb.2004.03.040 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66666774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960076004000895</els_id><sourcerecordid>66666774</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-23901e66209ad1f438d7a0345c7b7f49dfb660cea08710336944bd135396766f3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwBUgoG9gljB-xkwUgVJ5SJTYglpbjONRVHsVOKvr3uLQSrJjNbM6duToInWJIMGB-uUgWvmiKhACwBGgCDPbQGGcijzEhsI_GkHOIQXAYoSPvFwBAKRaHaIRTQtKMZWN0_T63eh5p6_RQq962H1FtVqaOuioiaTxfl677Wq9srxrbRneR9ZFaLl23dFb15uYYHVSq9uZktyfo7eH-dfoUz14en6e3s1jTLO1jQnPAhnMCuSpxxWhWCgWUpVoUomJ5WRWcgzYKMoFDSZ4zVpSYpjTngvOKTtDF9m54_TkY38vGem3qWrWmG7zkmxGCBZBuQe06752pZGjaKLeWGORGm1zIH21yo00ClUFbSJ3tzg9FY8rfzM5TAM53gPJa1ZVTrbb-D5dvOpPAXW05E2SsrHHSa2tabUrrjO5l2dl_i3wDwfSJ_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66666774</pqid></control><display><type>article</type><title>Which circulating level of 25-hydroxyvitamin D is appropriate?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lips, Paul</creator><creatorcontrib>Lips, Paul</creatorcontrib><description>Moderate Vitamin D deficiency causes secondary hyperparathyroidism and bone loss, leading to osteoporosis and fractures. Controversy exists which circulating level of 25-hydroxyvitamin D (25OH)D is appropriate. The high incidence of hip fractures at northern latitudes suggest a relationship with Vitamin D deficiency. However, international studies show lower serum 25(OH)D levels in southern than in northern Europe. Serum 25(OH)D was not a risk factor for hip fractures in several epidemiological studies. The required serum 25(OH)D is usually established by assessing the point where serum parathyroid hormone (PTH) starts to rise. This point varied in several studies between 30 and 78
nmol/l. However, interlaboratory variation may also influence the apparent required serum 25(OH)D level. Dietary calcium intake influences serum PTH and serum PTH may influence the turnover of Vitamin D metabolites. A low calcium intake causes an increase of serum PTH and serum 1,25(OH)2D thereby decreasing the half life of serum 25(OH)D. While a low calcium intake may aggravate Vitamin D deficiency, a high calcium intake may have a Vitamin D sparing effect. With current knowledge, a global estimate for the appropriate serum 25(OH)D is 50
nmol/l.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/j.jsbmb.2004.03.040</identifier><identifier>PMID: 15225848</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Calcium - administration & dosage ; Calcium intake ; Classification of Vitamin D status ; Fundamental and applied biological sciences. Psychology ; Hip Fractures - epidemiology ; Hip Fractures - etiology ; Humans ; Medical sciences ; Metabolic diseases ; Other nutritional diseases (malnutrition, nutritional and vitamin deficiencies...) ; Risk Factors ; Threshold serum 25(OH)D ; Vertebrates: endocrinology ; Vitamin D - analogs & derivatives ; Vitamin D - blood ; Vitamin D deficiency ; Vitamin D Deficiency - complications ; Vitamin D Deficiency - epidemiology ; Vitamin D replete states</subject><ispartof>Journal of steroid biochemistry and molecular biology, 2004-05, Vol.89 (1-5), p.611-614</ispartof><rights>2004 Elsevier Ltd</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-23901e66209ad1f438d7a0345c7b7f49dfb660cea08710336944bd135396766f3</citedby><cites>FETCH-LOGICAL-c385t-23901e66209ad1f438d7a0345c7b7f49dfb660cea08710336944bd135396766f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jsbmb.2004.03.040$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15936942$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15225848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lips, Paul</creatorcontrib><title>Which circulating level of 25-hydroxyvitamin D is appropriate?</title><title>Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>Moderate Vitamin D deficiency causes secondary hyperparathyroidism and bone loss, leading to osteoporosis and fractures. Controversy exists which circulating level of 25-hydroxyvitamin D (25OH)D is appropriate. The high incidence of hip fractures at northern latitudes suggest a relationship with Vitamin D deficiency. However, international studies show lower serum 25(OH)D levels in southern than in northern Europe. Serum 25(OH)D was not a risk factor for hip fractures in several epidemiological studies. The required serum 25(OH)D is usually established by assessing the point where serum parathyroid hormone (PTH) starts to rise. This point varied in several studies between 30 and 78
nmol/l. However, interlaboratory variation may also influence the apparent required serum 25(OH)D level. Dietary calcium intake influences serum PTH and serum PTH may influence the turnover of Vitamin D metabolites. A low calcium intake causes an increase of serum PTH and serum 1,25(OH)2D thereby decreasing the half life of serum 25(OH)D. While a low calcium intake may aggravate Vitamin D deficiency, a high calcium intake may have a Vitamin D sparing effect. With current knowledge, a global estimate for the appropriate serum 25(OH)D is 50
nmol/l.</description><subject>Biological and medical sciences</subject><subject>Calcium - administration & dosage</subject><subject>Calcium intake</subject><subject>Classification of Vitamin D status</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hip Fractures - epidemiology</subject><subject>Hip Fractures - etiology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Other nutritional diseases (malnutrition, nutritional and vitamin deficiencies...)</subject><subject>Risk Factors</subject><subject>Threshold serum 25(OH)D</subject><subject>Vertebrates: endocrinology</subject><subject>Vitamin D - analogs & derivatives</subject><subject>Vitamin D - blood</subject><subject>Vitamin D deficiency</subject><subject>Vitamin D Deficiency - complications</subject><subject>Vitamin D Deficiency - epidemiology</subject><subject>Vitamin D replete states</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EoqXwBUgoG9gljB-xkwUgVJ5SJTYglpbjONRVHsVOKvr3uLQSrJjNbM6duToInWJIMGB-uUgWvmiKhACwBGgCDPbQGGcijzEhsI_GkHOIQXAYoSPvFwBAKRaHaIRTQtKMZWN0_T63eh5p6_RQq962H1FtVqaOuioiaTxfl677Wq9srxrbRneR9ZFaLl23dFb15uYYHVSq9uZktyfo7eH-dfoUz14en6e3s1jTLO1jQnPAhnMCuSpxxWhWCgWUpVoUomJ5WRWcgzYKMoFDSZ4zVpSYpjTngvOKTtDF9m54_TkY38vGem3qWrWmG7zkmxGCBZBuQe06752pZGjaKLeWGORGm1zIH21yo00ClUFbSJ3tzg9FY8rfzM5TAM53gPJa1ZVTrbb-D5dvOpPAXW05E2SsrHHSa2tabUrrjO5l2dl_i3wDwfSJ_w</recordid><startdate>20040501</startdate><enddate>20040501</enddate><creator>Lips, Paul</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040501</creationdate><title>Which circulating level of 25-hydroxyvitamin D is appropriate?</title><author>Lips, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-23901e66209ad1f438d7a0345c7b7f49dfb660cea08710336944bd135396766f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Biological and medical sciences</topic><topic>Calcium - administration & dosage</topic><topic>Calcium intake</topic><topic>Classification of Vitamin D status</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hip Fractures - epidemiology</topic><topic>Hip Fractures - etiology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Other nutritional diseases (malnutrition, nutritional and vitamin deficiencies...)</topic><topic>Risk Factors</topic><topic>Threshold serum 25(OH)D</topic><topic>Vertebrates: endocrinology</topic><topic>Vitamin D - analogs & derivatives</topic><topic>Vitamin D - blood</topic><topic>Vitamin D deficiency</topic><topic>Vitamin D Deficiency - complications</topic><topic>Vitamin D Deficiency - epidemiology</topic><topic>Vitamin D replete states</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lips, Paul</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lips, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Which circulating level of 25-hydroxyvitamin D is appropriate?</atitle><jtitle>Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>2004-05-01</date><risdate>2004</risdate><volume>89</volume><issue>1-5</issue><spage>611</spage><epage>614</epage><pages>611-614</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>Moderate Vitamin D deficiency causes secondary hyperparathyroidism and bone loss, leading to osteoporosis and fractures. Controversy exists which circulating level of 25-hydroxyvitamin D (25OH)D is appropriate. The high incidence of hip fractures at northern latitudes suggest a relationship with Vitamin D deficiency. However, international studies show lower serum 25(OH)D levels in southern than in northern Europe. Serum 25(OH)D was not a risk factor for hip fractures in several epidemiological studies. The required serum 25(OH)D is usually established by assessing the point where serum parathyroid hormone (PTH) starts to rise. This point varied in several studies between 30 and 78
nmol/l. However, interlaboratory variation may also influence the apparent required serum 25(OH)D level. Dietary calcium intake influences serum PTH and serum PTH may influence the turnover of Vitamin D metabolites. A low calcium intake causes an increase of serum PTH and serum 1,25(OH)2D thereby decreasing the half life of serum 25(OH)D. While a low calcium intake may aggravate Vitamin D deficiency, a high calcium intake may have a Vitamin D sparing effect. With current knowledge, a global estimate for the appropriate serum 25(OH)D is 50
nmol/l.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15225848</pmid><doi>10.1016/j.jsbmb.2004.03.040</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-0760 |
ispartof | Journal of steroid biochemistry and molecular biology, 2004-05, Vol.89 (1-5), p.611-614 |
issn | 0960-0760 1879-1220 |
language | eng |
recordid | cdi_proquest_miscellaneous_66666774 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Biological and medical sciences Calcium - administration & dosage Calcium intake Classification of Vitamin D status Fundamental and applied biological sciences. Psychology Hip Fractures - epidemiology Hip Fractures - etiology Humans Medical sciences Metabolic diseases Other nutritional diseases (malnutrition, nutritional and vitamin deficiencies...) Risk Factors Threshold serum 25(OH)D Vertebrates: endocrinology Vitamin D - analogs & derivatives Vitamin D - blood Vitamin D deficiency Vitamin D Deficiency - complications Vitamin D Deficiency - epidemiology Vitamin D replete states |
title | Which circulating level of 25-hydroxyvitamin D is appropriate? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A49%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Which%20circulating%20level%20of%2025-hydroxyvitamin%20D%20is%20appropriate?&rft.jtitle=Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Lips,%20Paul&rft.date=2004-05-01&rft.volume=89&rft.issue=1-5&rft.spage=611&rft.epage=614&rft.pages=611-614&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/j.jsbmb.2004.03.040&rft_dat=%3Cproquest_cross%3E66666774%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66666774&rft_id=info:pmid/15225848&rft_els_id=S0960076004000895&rfr_iscdi=true |